ScienceGuide

Ovarian Tissue Cryopreservation - Can Freezing Your Ovaries Delay Menopause?

An interactive look to demonstrate how ovarian tissue freezing can affect the ovarian reserve: set the age, the amount banked and the number of returns, and see how far menopause moves.

October 23, 20265 min read

Short answer

Ovarian Tissue Cryopreservation (OTC) is where a surgeon removes a small part of the ovaries containing dormant eggs, freezes it, and returns it later in life, sometimes in several small portions. It is often used to preserve or extend natural fertility in young cancer patients, but its use is expanding. Observations suggest that returning young ovaries can extend ovarian function. The delay depends on how much cortex is banked, at what age, and how many follicles survive the transplant. Our collaborators’ model below shows how much delay might theoretically be gained.No outcomes have been measured in healthy women yet, so the numbers below are model estimates, not results.

Try the model

Set a scenario and watch the reserve curve move. Removing cortex early banks eggs before they are lost; returning them later lifts the curve back above the threshold for a while.

Menopause would arrive

About 8 years later

Around age 59 instead of 51.

+5 to +11 years depending on starting pool size

Tissue removed
30

Tissue returned
From about age 50

Menopause, no procedure: ~51

Menopause with procedure: ~59

203040506070Age (years)Eggs remaining (log scale)Menopause thresholdTissue removedTissue returnedMenopause, no procedure: ~51Menopause with procedure: ~59

With the procedureWithout itEach transplant

*The 40% starting value is based on the paper, which cites studies of transplanted human ovarian tissue.

What the procedure does

1. Remove2. Freeze3. Return

At age 30, 25% of all ovarian cortex (50% of one ovary)

Kept frozen in portions

From about age 50, 40% of eggs survive each transplant

Source

This visualization is reproduced here from NoPauze with their permission.

The model was published in the American Journal of Obstetrics and Gynecology by Johnson et al.[1] It is listed in our research library, and the paper is on PubMed.

LifeAhead's role

LifeAhead is developing a forecast of the approximate timing of the menopausal transition for clinicians to use in counseling. Our vision is to empower women with better personal information to make more informed fertility preservation decisions, like egg freezing or OTC. Read about the science.

Assumptions
  • Each transplant is timed for impending menopause, which in practice would be judged from hormone markers and cycle changes.[1]
  • Banked tissue does not age while frozen. This is why several small returns outperform one large one: eggs returned later were not being lost in the meantime.[1]
  • The chart shows a woman with a typical starting pool of eggs. A woman born with fewer gains less and should bank less, because removing a large share of her cortex could exhaust it.[1]
Limitations
  • No study has yet followed healthy women through planned tissue freezing and return to measure the delay. The model is built from how egg numbers decline over life, not from procedure outcomes.[1]
  • Follicle survival after transplant is uncertain. The calculator starts at 40%, the paper's conservative figure from tissue studies; higher survival depends on newer surgical and revascularization methods.[1]
  • The chart uses a typical starting pool. Your own reserve would need to be assessed, for example with anti-Mullerian hormone (AMH), before any of these numbers could apply to you. What AMH can and cannot tell you.
  • Tissue removal and transplant are surgeries with their own risks, and prolonging natural estrogen exposure has health trade-offs to weigh with a specialist.

References

  1. Johnson J, Lawley SD, Emerson JW, Oktay KH. Modeling delay of age at natural menopause with planned tissue cryopreservation and autologous transplantation. Am J Obstet Gynecol. 2024;230(4):426.e1-426.e8. doi:10.1016/j.ajog.2023.12.037

This article is for general education and does not replace advice from your healthcare provider.

This model has not been validated in a clinical study, and its claims have not been verified by the U.S. Food and Drug Administration. It describes a published mathematical model, not an available treatment or a recommendation.

Tags

ovarian tissue cryopreservationmenopause delayovarian reservemathematical modelinteractive